Skip to main content

Advertisement

SpringerLink
Log in

ACE-inhibitors-induced metabolic acidosis in a child with nephrotic syndrome

  • Brief Report
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

In recent years there has been an increase in the use of ACE inhibitors in the paediatric population. We describe a case of hyperchloraemic metabolic acidosis with hypoaldosteronism in a 4-year-old boy with nephrotic syndrome who was receiving ACE inhibitors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Gruppo Italiano Studi Epidemiologici in Nefrologia (GISEN) (1997) Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. Lancet 349:1857–1863

    PubMed  Google Scholar 

  2. Pennesi M, Torre G (2000) Angiotensin converting enzyme inhibition in non-diabetic nephropathy with non-nephrotic proteinuria. Pediatr Nephrol 14:438

    CAS  PubMed  Google Scholar 

  3. Sakemi T, Ohchi N, Sanai T, Rikitake O, Maeda T (1988) Captopril-induced metabolic acidosis with hyperkalemia. Am J Nephrol 8:245–248

    CAS  PubMed  Google Scholar 

  4. Henger A, Tutt P, Riesen WF, Hulter HN, Krapf R (2000) Acid-base endocrine effects of aldosterone and angiotensin II inhibition in metabolic acidosis in human patients. J Lab Clin Med 136:379–389

    Article  CAS  PubMed  Google Scholar 

  5. Bonnet F, Thivolet C (1996) Reversible hyperkalemia at the initiation of ACE inhibitors in a young diabetic patient with latent hyporeninemic hypoaldosteronism. Diabetes Care 19:781

    CAS  Google Scholar 

  6. Rodriguez-Soriano J, Ubetagoyena M, Vallo A (1990) Transtubular potassium gradient: a useful test to estimate renal aldosterone bioactivity in infants and children. Pediatr Nephrol 4:105–110

    Google Scholar 

  7. Textor SC, Bravo EL, Fouad FM, Tarazi RC (1982) Hyperkalemia in azotemic patients during angiotensin-converting enzyme inhibition and aldosterone reduction with captopril. Am J Med 73:719–725

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinica Pediatrica, IRCCS Burlo Garofolo, Università di Trieste, Via dell’Istria 65/1, 34100, Trieste, Italy

    Irene Bruno, Marco Pennesi & Federico Marchetti

Authors
  1. Irene Bruno
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marco Pennesi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Federico Marchetti
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Federico Marchetti.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bruno, I., Pennesi, M. & Marchetti, F. ACE-inhibitors-induced metabolic acidosis in a child with nephrotic syndrome. Pediatr Nephrol 18, 1293–1294 (2003). https://doi.org/10.1007/s00467-003-1282-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-003-1282-2

Keywords

Search

Navigation